Letsee imaging
  • Team
  • Contact

A breakthrough mammograph for early detection of breast cancer

Letsee Imaging is developing advanced imaging solutions, to provide every woman & man access to early and most accurate breast cancer detection. We are convinced that our technology will be the next gold reference in mammography.

More information

PARTNERS

Backed by Leading institutions

HOW IT WORKS

Key features about mammography

Breast cancer is the first cause of death for women. Mammography remains the reference diagnostics.

Breast cancer mortality in high-income countries dropped by 40% between the 1980s and 2020, thanks to the organized screening: 1 mammography every 2 years after 50 years.

1 in 8 women

1/8 women will develop breast cancer in their lifetime. Half of all breast cancers occur in women with no specific risk factors.

2 300 000 women

2.3 millions women diagnosed with breast cancer in the world in 2022.

670 000 deaths

670 000 deaths annually worldwide in 2022. First cause of death for women.

6 / 10

6 / 10 cancers detected at an early stage.

TEAM

A team of excellence

Letsee Imaging, a spinoff from CNRS, was founded in November 2023 by Ombeline de La Rochefoucauld and Philippe Zeitoun, after 8 years of collaboration on X-rays imaging systems. Letsee Imaging is built on a skilled and dedicated team, advised by an internationally recognized strategic committee composed of entrepreneurs, radiologists, and scientists. Together, they combine expertise and innovation to advance healthcare.

More information

Credit : HEC Record

Saving lives through earliest
detection of breast cancer

Let’s get in touch !
Contact us : odelarochefoucauld@letseeimaging.com

  • LinkedIn